A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy

By afschroeder • April 8, 2026

Laxamana TD, Fervenza FC, Glassock RJ, Zand L. A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy. Clin Kidney J. 2026 Feb 26;19(4):sfag037. doi: 10.1093/ckj/sfag037. PMID: 41948118; PMCID: PMC13053080.

Tags: adrenal insufficiency, Emeritus, glucocorticoid toxicity, IgA nephropathy, Nephrology, Publications, targeted-release budesonide

Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab?

Giri K, Glassock RJ, Fervenza FC. Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab? Kidney Int Rep. 2026 Mar 4;11(4):106416. doi: 10.1016/j.ekir.2026.106416.[...]

Discharge criteria from nephrology follow-up back to primary care in modern-era CKD: a review of main guidelines

Oliva-Damaso N, Martinez-Palma L, Oliva-Damaso E, Payan J, Glassock RJ. Discharge criteria from nephrology follow-up back to primary care in modern-era CKD: a review of[...]

Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction

Zhu J, Cheng X, Bahramian M, Yao K, Li Z, Hu B, Wu TY, Sabet KA, Cui J, Tan J, Fang J, Li Y, Ho[...]